Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neuro-Oncology
•
Neurology
Do you use MR spectroscopy to differentiate between tumor progression versus radiation induced changes?
Related Questions
What approach do you use when treating adult diffuse gliomas with H3-G34 mutations, now classified into their own category under the 2021 glioma guidelines?
Based on the FIREFLY-1 data, would you consider using tovorafenib monotherapy front-line in pediatric patients who have low grade gliomas that are only amenable to subtotal resection or are unresectable?
When is the best time to try targeted therapy in adult-type diffuse non-IDH glioma?
How do you use Boswellia for radiation necrosis?
What is your approach to management of a subtotally resected pineal parenchymal tumor of intermediate differentiation (CNS WHO grade 2)?
Do you prescribe prophylactic steroids to patients receiving radiosurgery for AVMs?
Would you offer adjuvant radiotherapy for a gross totally resected WHO grade 2 hemangiopericytoma/MFT of the brain in a patient with active multiple sclerosis?
What was the rationale behind using RANO-HGG criteria instead of RAPNO criteria for the primary endpoint in the FIREFLY-1 trial for pLGG?
For those rare patients now out 5 years post GBM treatment and continuous Optune, is there a point one would stop Optune?
Would you recommend anticoagulation in a pediatric patient with metastases in a dural venous sinus?
